1. Academic Validation
  2. Nonspecific resistance to bacterial infections. Enhancement by ubiquinone-8

Nonspecific resistance to bacterial infections. Enhancement by ubiquinone-8

  • J Exp Med. 1978 Nov 1;148(5):1228-40. doi: 10.1084/jem.148.5.1228.
L H Block A Georgopoulos P Mayer J Drews
Abstract

A lipid fraction from Escherichia coli was extracted with apolar Solvents and was found to protect mice from a number of experimental Bacterial infections. The benzoquinone, ubiquinone-8, was isolated from this extract by high pressure liquid chromatography and identified as such by nuclear magnetic resonance and mass spectrometry. At a dose of 25 mg/kg this substance was found to provide complete protection against otherwise lethal infections with gram-negative and gram-positive bacteria in mice. Treatment was most effective when given intravenously 24 h before Infection. In comparative studies, ubiquinone-8 had a clearly higher activity than ubiquinones-4, Q6, and Q10. A highly significant increase in the clearance rate of bacteria from the blood by the spleen and the liver of treated Animals, correlated well with the protective effect of ubiquinone-8. The compound stimulated the ability of mouse macrophages to incorporate sheep erythrocytes and significantly increased the number of antibody-producing cells in spleens of mice.

Figures
Products